For the first time in Eastern India, the Gastroenterology team led by Dr Mahesh Kumar Goenka at Apollo Multispeciality Hospitals, Kolkata brings Power Spiral Enteroscopy, the latest and safest process to investigate and treat gastrointestinal tract diseases. This motorised type of endoscope would ease the process of endoscopy of small intestine and can be inserted through oral route as well as through rectum. While being safe, it is also a very effective technique for management and detection of small bowel pathology. On this note, Dr Surinder Singh Bhatia, DMS-Eastern Region, Apollo Hospitals Group, said, “Apollo Multispeciality Hospitals, Kolkata, continues to be the leader in bringing in new technologies and performing path-breaking procedures. Our committed clinicians, with the help of this state-of-the-art technology, would help many needing gastro interventions.” The small intestine is a 20 feet long part of gastrointestinal tract which is site of common diseases like Tuberculosis, Crohn’s disease, Drug induced ulcers, Vascular malformation etc. Till 20 years back, it was inaccessible by endoscope. Capsule Endoscopy and Balloon assisted enteroscopy have been developed but they have the disadvantage of difficult and tiring manoeuvrability. In order to make the entire procedure easy for the patients and to aid doctors, Apollo Multispeciality Hospitals, Kolkata, has recently introduced Power Spiral Enteroscopy, a motorised type of endoscope equipped with a special motor. On this Dr Mahesh Kumar Goenka, Director, Institute of Gastrosciences and Liver, Apollo Multispeciality Hospitals, Kolkata said, “This technique of endoscopic evaluation of the small bowel allows inspection of this 20-ft long small intestine with the pressing of a foot paddle just like driving a car with steering, accelerator and a break. It not only aids in treating complex conditions in the small intestine but also improves diagnosis and patient outcomes for chronic and complex intestinal conditions.” The PowerSpiral allows for fast and gentle access to reach deep into the gastrointestinal tract by pleating the small bowel onto the enteroscope using a spiral segment. This is achieved via an integrated motor, which rotates the single-use PowerSpiral cover tube that is equipped with soft spiral-shaped fins that gently follow the mucosa. The enhanced insertion speed, easy advancement, controlled withdrawal- and improved manoeuvrability can substantially reduce the overall procedure time and allow time for effective treatment. The motorized advancement, combined with the soft fins of the spiral segment, enables smooth, safe and deep insertion as well as excellent manoeuvrability, making it possible to see the entire intestinal lumen. All of these combined features make it easier to penetrate deep into the small bowel. The gentle grip on the mucosa between the soft fins of the spiral segment enables precise positioning of the endoscope. The integrated water jet keeps the view clear throughout the process. Thanks to the conventional endoscope channel, PowerSpiral allows for efficient interventions with a broad range of endotherapeutic devices. Due to the improved overall manoeuvrability, lesions may be reached more quickly. The first study results demonstrated that procedure times with the PowerSpiral endoscope may be substantially reduced Power spiral can be used for taking biopsy, removing small tumors, dilating narrowing, removing foreign bodies and stopping bleeding. The entire process is not only complete but also very fast compared to earlier techniques and also safe because of its inherent safety devices. The procedure is done under sedation and is therefore pain free. Benefits of Power Spiral Enteroscopy: Complete inspection of small intestine Rapid Safe Painless Can be used for obtaining biopsy Can treat small intestinal diseases

Apollo Hospitals has commenced the Covid-19 vaccination program for children in the age group of 15 to 18 years. This is in line with the Hon’ble Prime Minister’s announcement of expansion of the COVID vaccination program to include children above the age of 15 years from January 3, 2022. Dr Prathap C Reddy, Founder and Chairman, Apollo Hospitals Group said, “Today is indeed an important milestone in our battle against COVID-19. With the launch of vaccinations for children between 15-18 years, we have made a beginning in protecting our future and the future of the country. This is an age group that needs to be protected against COVID and vaccination will help in mitigating the severity and preventing complications of COVID in children. Timely vaccination will also help in their return to normal life of not just education in the classroom but also sports and other cultural activities necessary for all-round development.” Apollo Hospitals is India’s largest private vaccination provider and has been at the frontline in supporting the Government’s COVID vaccination program since it began in January 2021. Apollo Hospitals has all the infrastructure and necessary arrangements in place to vaccinate citizens of the newly eligible age-group. Following the coverage of the adult population, The Ministry of Health and Family Welfare has issued guidelines for COVID vaccination for children aged 15-18 years. Based on this directive, Apollo Hospitals has launched the Paediatric COVID Vaccination Programme for 15 – 18 year olds. The vaccine administered would be Covaxin, which has received emergency use approval for use in children by the Drugs Controller General of India (DCGI). Covaxin would be administered in two doses at a gap of 28 days. Registration of children in the eligible age group and categories can book the vaccination time-slots in the Apollo 24/7 or can register online with their school ID card / Aadhaar card using the Co-WIN App or by visiting the Co-WIN website. Aadhaar card or any other national identity card or school ID cards can be used for registration.

Apollo TeleHealth has become the first ever organisation in the world to attain the certification of ISO 13131:2021 presented by the British Standards Institution (BSI). The release of ISO 13131:2021 provides direction with a focus on the quality and risk management methods required to define guidelines for distinct remote health and care services. ISO 13131:2021 belongs to a class of standards that provides flexible, general guidelines that support innovation in healthcare. While the ISO 13131:2021 offers recommendations on standards that can be used to help in the development of telehealth services, the responsibility for developing appropriate guidelines for each health service remains with each organisation. Achieving certification of this standard showcases a provider’s capability of managing quality, safety, and patient data security effectively in this new age of telehealth service provisions. “Our business is providing medical care and assistance to millions of people around the country and worldwide. Therefore, it is vital that we employ strict processes to ensure quality in the delivery of telehealth services. We invest heavily in quality programmes and this certification recognises our industry leadership in developing and deploying user-friendly technological solutions and the high standard for medical services across our platform. By achieving certification of ISO 13131:2021, Apollo TeleHealth has demonstrated that it has adopted best practice for its telehealth services, a requirement for delivering safe healthcare from a distance” said Dr. Prathap C. Reddy, Founder and Chairman, Apollo Hospitals Group. Speaking of this new achievement, Dr. Sangita Reddy, Joint Managing Director, Apollo Hospitals Group said “As early as 1999, the Apollo Hospital Group decided to extend its outreach and initiated the process of providing healthcare to suburban and rural India by adopting Information and Communication Technology through the telemedicine platform. After more than two decades, Apollo TeleHealth (ATH) is the oldest and largest multispecialty telemedicine network with more than 13 million lives touched. Today, ATH has emerged as India’s single largest turnkey provider in the area of telemedicine with 800+ public health centres, 100+ franchised teleclinics and point of presence through 350,000 common service centres, and rapidly expanding to other geographies. It has brought healthcare within the reach of every consumer by the usage of the latest technologies, thereby Enabling Connected Health and Continuum of Care. The achievement of this new ISO standard is a reflection of the dedication, effort and perseverance of everyone associated with ATH to make it the global pioneer in telemedicine.” While most countries have national safety and quality health service standards, but Apollo TeleHealth has advanced to encompass how to govern remote delivery of health and care services – further emphasizing the role of this important standard. ISO 13131:2021. “By achieving the ISO 13131:2021 certification, ATH has demonstrated that it will work tirelessly to achieve the quality standards that its clients, candidates, employees and all stakeholders demand. With this certification, ATH’s technology, people and process have been vetted against rigid quality standards outlined by ISO. I am extremely proud of my team for their achievement, which proves theirs and the company’s commitment to ensuring quality and providing the best possible service to urban and rural populations worldwide. The ongoing crisis has made telemedicine mainstream. We were geared to meet the challenges and provide teleconsultations to thousands of patients. Through our service delivery model, we were successfully able to increase access to quality healthcare at a time when barriers were at an all-time high. We are dedicated to constant improvement and development and already thinking in terms of a post-COVID telemedicine landscape and working vigorously towards it” said Mr. Vikram Thaploo, CEO, Apollo TeleHealth.

Apollo Hospitals, Chennai has successfully used advanced Brain Sensing technology in Deep Brain Stimulation on patients suffering with Parkinson’s disease. Deep Brain Stimulation (DBS), is a neurosurgical procedure that involves implanting electrodes deep inside the brain to improve symptoms of Parkinson’s disease. The use of advanced brain sensing technologies helps in individualized monitoring that maximizes therapeutic outcome. The advanced movement disorders team at Apollo Hospitals have performed five DBS surgeries in last month, that included four patients of Parkinson’s disease and one with dystonia. All the patients have recovered well with good improvement in their symptoms. Ms. Preetha Reddy, Vice Chairperson, Apollo Hospitals Group said, “At Apollo Hospitals, we have been performing DBS surgery since 14 years now. Well-established as a therapy for patients diagnosed with advanced Parkinson’s disease, the procedure is now used for many other neurological indications with good success. With one of the most experienced teams in South India backed by the latest medical technology, we are sure that we will be able to help many Indian patients with Parkinson’s and other neurological disorders to regain their quality of life. Read more about how Deep Brain Stimulation changed many patients’ lives

Apollo Cancer Centres (ACC), ranked among the top super specialty hospitals, offering advanced tertiary care in Oncology, Neurology and Neurosurgery, among others, gives a new ray of hope to international patients from Chile, Iran, Myanmar and Sri Lanka who were diagnosed with various cancers. Hon’ble Tamil Nadu Health Minister Thiru. Ma. Subramanian visited Apollo Proton Cancer Centre and interacted with International Patients on their visit to Chennai for Cancer treatment in the presence of Ms. Preetha Reddy, Executive Vice Chairperson, Apollo Hospitals Groups, Mr. Harshad Reddy, Director-Operations, Apollo Proton Cancer Centre, among other dignitaries. Read more about the International Patients visiting Apollo Hospitals for Cancer treatment

For the first time in Eastern India, doctors at Apollo Multispecialty Hospitals gave a new lease of life to an unborn baby by a blood transfusion inside womb. Mrs. Rima was diagnosed with a rare complication of foetal hydrops during her 24th week of pregnancy where fluids get accumulated in the foetus, making the baby anemic. Dr Mallinath Mukherjee, Apollo Multispeciality Hospitals said, “In such cases, blood transfusion to the unborn is the only way to save the baby’s life. Even with treatment, survival rate of such babies is extremely low. In this case we have been able to successfully deliver the baby at 35 weeks of pregnancy after 6 blood transfusions. We are also grateful to the health department of the state for their support in this special delivery.” Read more about how doctors successfully performed first blood transfusion inside the womb

Apollo Hospitals Group has announced free vaccinations against COVID-19 for children with specified co-morbidities across the hospital network. It is anticipated that approval will soon be granted for vaccinating children with specified co-morbidities and immediately post-approval and details of the age-group permitted for vaccination, the free vaccination initiative would be launched by Apollo Hospitals. The list is expected to include children with haematological, neurological, cardiac, liver, gastrointestinal, rheumatic, respiratory, genitourinary, and developmental disorders as well as cancers. However, this is an indicative list and the final list of co-morbidities eligible for free vaccination would be as per the list published by the Government. Dr Prathap C Reddy, Chairman, Apollo Hospitals Group said, “Adults have been the focus of vaccination till now as by and large, children have been spared from severe COVID 19 infection. However, this is not the case in children with co-morbidities. These children continue to be at high risk of developing a severe infection. In addition, children with comorbidities have also seen a significant psychosocial impact as the lockdown resulted in their missing out on the personalized attention and specialized treatment and care that they require. The Government’s approval of vaccinations for children with co-morbidities, when it comes through, will be a welcome step in the right direction. Realising the criticality of this vaccination, we will be extending the COVID vaccines completely free of cost to children with co-morbidities and giving them the necessary ‘Kavach’ (shield) against COVID!” Apollo Hospitals has been at the frontlines of battle against COVID-19 since the beginning of the pandemic and is today the largest private sector vaccinator in the country with over 5 million vaccine doses administered. The vaccination program for children and adolescents will help to protect the future of the nation from COVID-19. There are two vaccines awaiting EUA by the Government and these are: Covaxin: For ages 2-18 years. Two doses at a gap of 28 days. Administered intra-muscularly ZyCov-D: For ages 12-18 years. Three doses at a gap of 28 days. Needle free vaccine administered intra-dermally. Both vaccines would be available at Apollo Hospitals’ vaccination centers across the country, once all Government approvals are in place and the vaccines are made available. For further details, please contact Dr Rohini Sridhar, Senior Vice President – Medical Services, Apollo Hospitals at drrohini_s@apollohospitals.com

FLO, the women’s wing of FICCI, joined hands with Apollo Cancer Centre for India’s First Virtual Duathlon – Apollo D2D. Dr. Preetha Reddy, Executive Vice Chairperson, Apollo Hospitals Group along with Ms Jeyasree Ravi, Chairperson FICCI Flo- Chennai Chapter and Founder, Sri Palam Silks and Dr. Sangita Reddy, Joint Managing Director of Apollo Hospitals and Immediate Past President FICCI participated in the duathlon event along with 50 other members from FLO. Apollo D2D Duathlon 2021 aims to create awareness, support and raise funds for the treatment of childhood cancers. Sharing her thoughts, Dr. Preetha Reddy, Executive Vice Chairperson, Apollo Hospitals, said “ApolloD2D Duathlon was envisaged to strengthen India’s fight against cancer. Therefore, Apollo Cancer Centres and Neville Endeavours Foundation (NEF) joined hands to heighten awareness, and garner support for the treatment of underprivileged pediatric cancer patients. It is our responsibility that we persevere to ensure that every child has the opportunity to bloom to their fullest, as they represent our nation’s future. Today, I am very grateful to all the wonderful members of FICCI-FLO who have joined us to support this cause. I would also request everyone to participate, cross the finish line and give a child, new hope!” Commenting on the occasion, Dr. Sangita Reddy, Joint Managing Director of Apollo Hospitals and Immediate Past President FICCI, said, “I would like to extend my gratitude to all the wonderful women from FICCI-FLO who are here to support & participate in the Apollo D2D Duathlon. Special thanks to Ms Jeyasree Ravi. We encourage more participation in the coming days and hope that together we can build more awareness about Childhood cancer and raise funds for their treatments.” Sharing her thoughts, Ms. Jeyasree Ravi, Chairperson FICCI FLO – Chennai Chapter and Founder, Sri Palam Silks, said “It gives me great pleasure in supporting a dear friend of mine in this very noble endeavor. Childhood cancer is indeed an important issue that needs to be addressed so that our leaders of tomorrow are safe & healthy. I would also like to express my gratitude to all the members from FLO who have joined me here today for this honorable cause.” To participate in the Apollo D2D Duathlon 2021, participants have to register on the website https://www.apollod2d.com The participants can register and complete the race on their own within 15th October to 14th November 2021. The participants can run, walk, or cycle to cover the distance of 3KM – 125 KM at their own pace and location of their choice. People can choose to cycle or run or both. The participants can use simple watch or stopwatch to note their time or can go for GPS watches, smart-watches, or activity tracking apps on smartphones. Read More about Apollo D2D flagged off in Chennai

For the first time in Eastern India, doctors at Apollo Multispecialty Hospitals, Kolkata gave a new lease of life to an unborn by interstitial laser therapy using a Diode laser. In Interstitial Diode Laser Therapy, a fine needle is inserted into the mother’s womb to release laser beams to terminate one twin pregnancy in order to save the healthier co-twin. The procedure is conducted with continuous support of ultra sound. Dr Jayanta Kr Gupta, Director & HOD Obstetrics & Gynaecology at Apollo Multispecialty Hospitals, Kolkata said, “It’s indeed a tough decision for parents to let go of one of the twins before birth, but this is the only way to save the other baby or else both the babies can’t live. We here at Apollo Hospitals for the very first time in Eastern India did the procedure of Interstitial Laser Therapy so that we can at least save one of the twins. The treatment was applied in a case of Twin-to-twin-transfusion syndrome (TTTS), which is unique to identical twins, who by nature get their nutrition supplied by single placenta. Twin-to-twin-transfusion syndrome ensures that mothers don’t lose both their babies due to this condition of intrauterine growth restriction. For this, early detection through regular check-ups including USG is critical during pregnancy.” Know more about how doctors gave a new lease of life to an unborn baby

TAVR or Transcatheter Aortic Valve Replacement, a percutaneous procedure, was successfully carried out on a 73-years-old female patient at Apollo Hospitals, Guwahati. The patient presented with breathing difficulties, chest pain on exertion and easy fatigability, and was admitted at Apollo Hospitals Guwahati, where she was diagnosed with a critical condition of severe calcific stenosis of the aortic valve. The only alternative was a valve replacement that had to be carried out immediately. Open-heart valve replacement surgery was not an option due to age and co-existing health issues. The patient was offered the advanced option of TAVR or Transcatheter Aortic Valve Replacement (TAVR), an advanced percutaneous technique that allows intervention on patients who are unsuitable or are at intermediate to high risk for open-heart surgery. The advanced procedure was successfully performed on 1st September 2021. The patient recovered well without any significant peri procedural event and discharged in the next few days in a healthy condition. Dr. Rituparna Baruah, Senior Consultant, Interventional Cardiologist at Apollo Hospitals, Guwahati said, “Patients with calcification of the leaflets of the heart valve, that open and close with the flow of blood, often present with symptoms only after the age of 70-75 years. However, if not treated, survival is difficult. TAVR is a revolutionary technique and a blessing for such patients so that they can have a prolonged healthy lifestyle with improved quality of life. Whereas in conventional open heart surgery, the chest cavity needs to be opened by cutting through the sternum to allow the surgeon to operate on the heart, TAVR is a percutaneous technique where it is accessed via needle-puncture of the skin, rather than a scalpel.” In TAVR, an artificial aortic valve is inserted through a catheter, a thin flexible tube, from the groin into a blood vessel, under local anaesthesia. The deployed valve reaches the base of the aorta at the site of the aortic valve. The doctor then opens a balloon that inflates the valve pushing aside the old valve and overcoming the stenosis or narrowing. Using Monitored Anaesthesia Care (MAC anaesthesia), the patient remains aware but relaxed throughout the procedure that takes about an hour as compared to 5-6 hours required for an open-heart surgery. There is no need of General Anesthesia and a midline sternal incision, which is required in open heart surgery is not done in TAVR, thereby reducing prolonged hospitalization, and instead of a week’s stay, a patient who has undergone TAVR goes back home walking on the third day. The other benefits of TAVR include reduced and negligible need for blood transfusions, and reduced stroke risk of less than 1% as against 5-7% in conventional open-heart surgery. Dr. D J Dutta, Senior Consultant Interventional Cardiologist at Apollo Hospitals, Guwahati said, “We are proud of having pulled off this feat at a time when the nation is fighting against COVID pandemic. Reports suggest over 5 lakh elective surgeries were postponed across the country. However, in this case, we couldn’t afford to wait for long, as any delay could have worsened the patient’s condition and could have been fatal.” Dr. Rondeep K N Sivam, Consultant Interventional Cardiologist at Apollo Hospitals, Guwahati who assisted in this procedure said “This is the first case of its kind in the state of Assam. Having access of such advanced technology will largely benefit the people of Assam and neighboring areas.” Dr. J P Kalita, Chief Cardiac Surgeon at Apollo Hospitals, Guwahati said “Transcatheter Aortic Valve Implantation (TAVI) or Replacement (TAVR) is approved for intermediate to severe risk patients with severe aortic stenosis (AS). This technique was already worldwide adopted for inoperable and high-risk patients. Improved device technology, imaging analysis and operator expertise has reduced the initial worrisome higher complications rate associated with TAVR, making it comparable to surgical aortic valve replacement (SAVR).”

Apollo Hospitals, Hyderabad has launched Varian’s TrueBeam radiotherapy system with Velocity, an intelligent software solution for Interventional Oncology at Apollo Cancer Institute, Apollo Health City campus, Hyderabad. The versatile TrueBeam is capable of treating a wide range of cancers with high accuracy and precision, allowing oncologists or cancer specialists to treat many types of complex cancer cases. Patients also benefit due to the comfort, accuracy, and speed permitted by the TrueBeam system. The addition of the specialized software, Velocity, organizes patient data and makes it available in one place to help clinicians make more informed treatment decisions. Chief Guest Dr. (Smt.) Tamilisai Soundararajan, Hon’ble Governor of Telangana and Hon’ble Lt. Governor of Puducherry had inaugurated Telangana’s first and only Truebeam STx with Velocity at Apollo Cancer Centre, Jubilee Hills. Speaking on the occasion, she said, “Apollo is known for offering the best care available in the world. It’s a moment of pride for Apollo Health City to have this state of the art TrueBeam radiotherapy system with Velocity. It also a moment of pride for the entire state of Telangana to have the latest and the only TrueBeam radiotherapy. The evolution of radiation therapy has enabled to deliver differential doses within the target volume, ranging from zero to 100% dose. Today, with the latest TrueBeam machine we have the capacity to treat cancer with all the very best of technology put together in 6D robotic couch and CG Image guidance for best accuracy in treatment. It delivers highly precise intensity modulated radiotherapy in the shortest possible time where the patient gets to go home in 1 to 3 days with the least possible side effects. All these go a long way to get the patient the best treatment with minimal side effects. Cancer has been a rising threat with alarming statistics, in 2020 we saw around 13.25 lakh new cases of cancer in India, with 8.5 lakh deaths due to cancer. We must be cautious and concerned, it is estimated that by 2025, there will be 12% rise in cancer cases. It is a matter of concern that in 1990 there were 54 cancer patients per lakh population in Telangana and the incidence has since risen to 75 per lakh in less than three decades time. TrueBeam enables to access advanced care without the need for patients to go abroad, she added.” Ms. Shobana Kamineni, Executive Vice Chairperson Apollo Hospitals Groups said, the launch of the TrueBeam LINAC with Velocity is another milestone in Apollo Hospitals’ battle against cancer, one of the dreaded non-communicable diseases that in just the last year has seen over 13 lakh new cases and over 8.5 lakh deaths. With TrueBeam LINAC, our patients can rest assured that they will receive the most advanced radiotherapy techniques with the added benefits of a high degree of accuracy and a shorter treatment time for a successful treatment. In line with our move to an increased degree of digital healthcare, the Velocity software will provide our oncologists with the tools for data-driven clinical decision making, that will help to reduce the mortality and morbidity from cancer. Apollo’s mission from day one has been to bring the best of care to every individual and to make it affordable. Many of the technologies we offer in our hospitals are the latest in the world available at a fraction of the treatment cost abroad. Not just Indians, many people from across the globe come to Apollo to find cure. The recurrence of cancers has seen a steep 50% increase from 1990 to 2020. With resources that hospitals like ours have, along with most our proficient doctors with unparalleled knowledge and skills as Chairman Dr Prathap C. Reddy always says, cancer is no more a death knell. TrueBeam has been used for treating patients in over 90 countries and every year around 1.5 million patients receive treatment on a TrueBeam linear accelerator (LINAC). TrueBeam is Varian’s most advanced LINAC, with the system incorporating many technical innovations that intuitively and dynamically synchronize imaging, patient positioning, motion management, and treatment delivery. TrueBeam uses intelligent automation that not just simplifies the workflow, but also guides the specialists step-by-step through each radiotherapy treatment. The Velocity software organizes patient data and makes it available in one place, allowing the oncologist to access and compile treatment and imaging data from diverse systems for a comprehensive view of a patient’s diagnostic imaging and treatment history. This leads to more informed treatment decisions by facilitating close collaboration between physicians, oncologists, medical physicists, and others on the team. It also helps in cases of retreatment for recurrence or metastases. Dr Vijay Anand Reddy, Director Oncology, Apollo Cancer Center at Apollo Hospitals, Hyderabad said, “The TrueBeam platform with Velocity provides us with the tools to manage and treat our patients optimally. Many times, a patient has multiple treatments over a long period or even after a gap, especially if metastatic lesions occur months or even years later. It is here that the Velocity software allows the treating doctors to understand a patient’s full clinical history and reach a judicious decision about the way forward. It puts more power into the hands of the oncologist with a comprehensive view of a patient’s diagnostic imaging and treatment history, regardless of where they were treated or what technology was used. Velocity makes it possible to manage the entire cancer treatment journey from diagnosis to completion of treatment.”

Apollo Hospitals finds pride of place in the Best Specialized Hospitals 2022 ranking released by Newsweek, the premier international news magazine and website. The ranking in partnership with global research firm Statista ranks the world’s best specialized hospitals and features the top 250 hospitals for cardiology and oncology and the top 150 for pediatrics among ten specialities. The Apollo Heart Centre at Apollo Hospitals, Chennai makes it to the list of Best Specialized Hospitals 2022 – Cardiology with a global rank of 126 and ranks No. 1 among the five Indian hospitals in the list. In the Best Specialized Hospitals 2022 – Oncology, two hospitals from the Apollo Hospitals Group make it to the list with Apollo Cancer Centres at Apollo Speciality Cancer Hospital, Chennai and Apollo Hospitals, Chennai ranked at 228 and 239 respectively. The two hospitals are among just four Indian hospitals that are in list for Oncology. In the Paediatric speciality, Apollo Children’s Hospital, Chennai is ranked at 103 globally and is one among just five Indian hospitals that are part of the Best Specialized Hospitals 2022 – Paediatrics ranking. This global recognition is testament to the specialty healthcare of international standards provided at Apollo Hospitals with outcomes matching those of the world’s best hospitals. Apollo Hospitals, with some of the world’s finest and brightest medical experts, has been the pioneer in bringing ground-breaking healthcare technologies to India to deliver best in class clinical results.